top of page


New era in nasopharyngeal cancer: Toripalimab opens doors for immunotherapy.
For decades, nasopharyngeal cancer patients facing recurrent or metastatic disease had limited treatment options.
3 min read
Â
Â


Can we fight the hidden breast cancer cells that survive chemotherapy?
October is observed as Breast Cancer Awareness Month worldwide and we all know that early detection is crucial for curing cancer.
3 min read
Â
Â


Is CAR T-cell therapy a boon for acute lymphoblastic leukemia patients??
Acute lymphoblastic leukemia (ALL) is the most prevalent cancer subtype among all the leukemias that occur in children.
3 min read
Â
Â


Lenvatinib plus pembrolizumab improved survival outcomes in advanced endometrial cancer
Uterine cancer is the second most prevalent Gynecological cancer in the world and it has high incidence rates in developed countries.
3 min read
Â
Â


Can olutasidenib help in acute myeloid leukemia treatment?
Acute myeloid leukemia (AML) is a malignancy of the blood and bone marrow.
4 min read
Â
Â


Is durvalumab a breakthrough treatment for gallbladder cancer?
Gallbladder cancer (GBC) is one of the most prevalent among biliary tract duct cancers globally.
3 min read
Â
Â


Unlocking new hope: Dostarlimab shakes up the colorectal cancer treatment approach
Colorectal cancer is one of the most prevalent and fatal types of cancer worldwide.
4 min read
Â
Â


Revolutionizing cervical cancer treatment: the promising role of Nelfinavir
Cervical cancer is the most prevalent gynecologic malignancy, accounting for over 600,000 cases worldwide each year.
3 min read
Â
Â


Is avelumab hold the promise of being a breakthrough treatment for gastric cancer?
Gastric cancer develops in the lining of the stomach and is one of the most common gastrointestinal malignancies, worldwide.
4 min read
Â
Â


Will nanotechnology help in the remission of liver cancer??
Liver cancer is one of the common types of malignancy that originates from the hepatocytes (liver cells).
4 min read
Â
Â


Can nanotechnology be used to treat HER2-positive breast cancer?
Breast cancer is one of the most heterogeneous types of cancer and the primary cause of death for women worldwide.
3 min read
Â
Â


Current treatment option for chest wall Ewing Sarcoma
Chest wall Ewing sarcomas, historically known as skin tumors, are tumors formed by a particular type of bone or soft tissue cell.
4 min read
Â
Â

Get new content delivered directly to your inbox.
bottom of page